APPARATUS FOR AND METHOD OF CONSTRUCTING PANELIZED ROOF STRUCTURES
    5.
    发明申请
    APPARATUS FOR AND METHOD OF CONSTRUCTING PANELIZED ROOF STRUCTURES 审中-公开
    构造面板屋顶结构的装置和方法

    公开(公告)号:WO2003078118A1

    公开(公告)日:2003-09-25

    申请号:PCT/US2003/007777

    申请日:2003-03-12

    CPC classification number: B27F7/003 B27M3/0073

    Abstract: A portable roof panel structure assembly mechanism (100) that may be transported to a construction site and that is used to automatically assemble roof panel structures at the site. The assembly mechanism includes a purlin feeder (102), subpurlin clamping mechanisms (106) and feeders (104), and a diaphragm feeder (108). The purlin feeder (102) lifts a purlin into position, and advances the purlin into an assembly station (110). The subpurlin feeders (104) insert a subpurlin into each of a plurality of subpurlin clamping mechanisms, and the clamping mechanisms advance into the assembly station (110) and hold the subpurlins against the section of the purlin that has been advanced. The diaphragm feeder (108) places a diaphragm onto the subpurlins and the purlin at the assembly station (110). The components are attached by automatic nailers.

    Abstract translation: 一种便携式屋顶板结构组装机构(100),其可以运输到施工现场并用于在现场自动组装屋顶板结构。 组装机构包括pur条进料器(102),亚螺旋夹紧机构(106)和进料器(104)以及隔膜进料器(108)。 pur条进料器(102)将pur条提升到适当的位置,并将pur条推进装配站(110)。 脊髓输送器(104)将亚急性髓鞘插入到多个亚型螺钉夹持机构中的每一个中,并且夹紧机构前进到组装工位(110)中,并且将该副螺旋束紧靠在已经前进的pur条部分。 隔膜进料器(108)将膜片放置在装配站(110)上的子纸浆和pur条上。 组件通过自动钉枪连接。

    HETEROCYCLIC-SUBSTITUTED PYRROLOPYRIDINES AND PYRROLOPYRIMIDINES AS JAK INHIBITORS
    6.
    发明申请
    HETEROCYCLIC-SUBSTITUTED PYRROLOPYRIDINES AND PYRROLOPYRIMIDINES AS JAK INHIBITORS 审中-公开
    作为JAK抑制剂的杂环取代的吡咯烷酮和吡咯烷酮

    公开(公告)号:WO2012068440A1

    公开(公告)日:2012-05-24

    申请号:PCT/US2011/061351

    申请日:2011-11-18

    CPC classification number: C07D487/04

    Abstract: The present invention provides heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines of Formula I: wherein X, Y, Z, L, A, R 5 , n, m, and r are defined above, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

    Abstract translation: 本发明提供式I的杂环取代的吡咯并吡啶和吡咯并嘧啶:其中X,Y,Z,L,A,R 5,n,m和r如上所定义,以及它们的组合物和使用方法, Janus激酶(JAKs)的活性,并且可用于治疗与JAK的活性相关的疾病,包括例如炎症性疾病,自身免疫性疾病,癌症和其它疾病。

Patent Agency Ranking